Duncker Streett & Co. Inc. Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Duncker Streett & Co. Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 9.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,531 shares of the healthcare conglomerate’s stock after purchasing an additional 1,220 shares during the quarter. UnitedHealth Group comprises 1.5% of Duncker Streett & Co. Inc.’s holdings, making the stock its 13th largest position. Duncker Streett & Co. Inc.’s holdings in UnitedHealth Group were worth $7,124,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of UNH. Robbins Farley purchased a new position in UnitedHealth Group during the third quarter valued at approximately $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC grew its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the period. NewSquare Capital LLC grew its holdings in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA grew its holdings in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $23.26 during trading hours on Wednesday, hitting $468.89. The stock had a trading volume of 11,816,517 shares, compared to its average volume of 4,248,641. The firm has a market capitalization of $432.28 billion, a PE ratio of 19.68, a PEG ratio of 1.22 and a beta of 0.54. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The stock’s 50 day moving average is $490.31 and its 200 day moving average is $515.63. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.54 by $0.37. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period last year, the company earned $6.26 earnings per share. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Bank of America reaffirmed a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Morgan Stanley lowered their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Piper Sandler lowered their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 17th. Finally, HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research note on Thursday, April 4th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $573.80.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.